关于 "Reverse Transcriptase" 的结果28+ 个结果

Reverse transcriptase-IN-1 (Compound 12z)，二芳基苯并嘧啶 (DABP) 类似物， 是一种有效的，具有口服活性的 HIV-1 非核苷逆转录酶抑制剂。Reverse transcriptase-IN-1 具有抗病毒活性，对 HIV-1 IIIB，E138K 和 K103N 突变体的 EC50 值分别为 3.4 nM，4.3 nM 和 3.6 nM，而且对 HIV-1 逆转录酶的 IC50 值为 13.7 nM。

M-MLV Reverse transcriptase (M-MLV RT) 是一种逆转录酶，最早来源于莫洛尼鼠白血病病毒 ( Moloneymurineleukemiavirus , MoMLV)。

A nucleoside reverse transcriptase inhibitor

A nucleoside reverse transcriptase inhibitor

A nucleoside reverse transcriptase inhibitor

A nucleoside reverse transcriptase inhibitor

A non-nucleoside reverse transcriptase inhibitor

A non-nucleoside reverse transcriptase inhibitor

A non-nucleoside reverse transcriptase inhibitor

A non-nucleoside reverse transcriptase inhibitor

A non-nucleoside reverse transcriptase inhibitor

An inhibitor of HIV reverse transcriptase

An HIV reverse transcriptase and HBV polymerase inhibitor

An HIV reverse transcriptase and HBV polymerase inhibitor

An inhibitor of reverse transcriptases and DNA polymerases

An antiviral nucleoside analog and inhibitor of reverse transcriptase

A triterpenoid with reverse transcriptase inhibitory and anti-inflammatory activities

A non-nucleoside reverse transcriptase inhibitor

An inhibitor of HIV reverse transcriptase

Elsulfavirine (Elpida, VM-1500) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) developed for the treatment and prevention of HIV-1 infection.

Cyanine 5-6-Propargylamino-2’-deoxyuridine-5’-Triphosphate can replace dTTP in many enzymatic reactions, as it is a substrate for many polymerases and reverse transcriptases.

Rilpivirine (TMC278), is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.

Tenofovir alafenamide (TAF, GS-7340) fumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels. Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection.

Asn-Ala-ICAM 1 (1-21) inhibits virus replication in HIV-1 infected HTLV-1 transformed cells (MT-2 cells). The peptide induces up to 70% inhibition of reverse transcriptase activity, up to 60% reduction of soluble virus antigen production, and inhibition of syncytium formation.